SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-20-009839
Filing Date
2020-04-22
Accepted
2020-04-22 17:02:05
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea120834-s3_adialpharma.htm S-3 492840
2 OPINION OF GRACIN & MARLOW, LLP ea120834ex5-1_adialpharma.htm EX-5.1 21327
3 CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM ea120834ex23-1_adialpharma.htm EX-23.1 2757
4 GRAPHIC img_001.jpg GRAPHIC 7429
5 GRAPHIC img_002.jpg GRAPHIC 7429
6 GRAPHIC ex5-1_001.jpg GRAPHIC 5333
  Complete submission text file 0001213900-20-009839.txt   546354
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237793 | Film No.: 20808465
SIC: 2834 Pharmaceutical Preparations